Nicotine & Tobacco Research · 2014 · 103 citations · 13 references
Public HealthBehavioral SciencesRisk AssessmentSubstance Use DisordersTobacco ControlNicotine AddictionNicotine DependenceTobacco DependenceTobacco UseTobacco Addiction
Electronic cigarettes (ECIGs) comprise an aerosolized nicotine delivery product category that provides consumers with probably unprecedented control over extensive features and operating conditions, allowing a wide range of nicotine yields to be obtained. Depending on the combination of such ECIG variables as electrical power input, geometry, liquid composition, and puff behavior, ECIG users can extract in a few puffs far more or far less nicotine than with a conventional combustible cigarette. These features of ECIG design and use present challenges for public health policy, central among which is the question of how to regulate nicotine delivery. In this commentary, we propose a conceptual framework intended to provide a convenient approach for evaluating and regulating the nicotine emitted from ECIGs. This framework employs nicotine flux to account for the total dose and rate at which nicotine reaches the user, 2 key factors in drug abuse liability. The nicotine flux is the nicotine emitted per puff second (e.g., mg/s) by a given ECIG design under given use conditions, and it can be predicted accurately using physical principles. We speculate that if the flux is too low, users likely will abandon the device and maintain conventional tobacco product use. Also, we speculate that if the flux is too high, individuals may suffer toxic side effects and/or the device may have higher-than-necessary abuse liability. By considering ECIG design, operation conditions, liquid composition, and puff behavior variables in combination, we illustrate how ECIG specifications can be realistically mandated to result in a target flux range.
13
Nicotine Levels in Electronic Cigarettes
Maciej Ł. Goniewicz, Tomasz Kuma, Jakub Knysak et al. · Nicotine & Tobacco Research · 2012 · 608 citations · Full text
Pharmacy, Pharmacology, Toxicology +13
Chris Bullen, Hayden McRobbie, Simon Thornley et al. · Tobacco Control · 2010 · 520 citations
Andrea R. Vansickel, Caroline O. Cobb, Michael F. Weaver et al. · Cancer Epidemiology Biomarkers & Prevention · 2010 · 378 citations · Full text
Medicine, Pharmacology, Toxicology +15
Soha Talih, Zainab Balhas, Thomas Eissenberg et al. · Nicotine & Tobacco Research · 2014 · 361 citations · Full text